Hormone Resistant Prostate Cancer Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
< b > Conditions < /b > : Hormone-Resistant Prostate Cancer; Stage IV Prostate Adenocarcinoma < br/ > < b > Interventions < /b > : Drug: Cabazitaxel; Drug: Prednisone < br/ > < b > Sponsors < /b > : University of California, Davis; Sanofi < br/ > < b > Not yet recruiting < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2016 Category: Research Source Type: clinical trials
